key: cord-0911192-gfwuxs4y authors: Dias, Lucas D.; Blanco, Kate C.; Bagnato, Vanderlei S. title: COVID-19: Beyond the virus. The use of Photodynamic Therapy for the Treatment of Infections in the Respiratory Tract date: 2020-05-08 journal: Photodiagnosis Photodyn Ther DOI: 10.1016/j.pdpdt.2020.101804 sha: 449eb6367f80a451950093fc6887cc8150a2f546 doc_id: 911192 cord_uid: gfwuxs4y • •The World today is facing a great effort for the control of infections. • •Nowadays COVID-19 is the large global outbreak and is the major public health issue. • •This letter to Editor highlighted the well-established photodynamic therapy protocol as a tool to decrease the viral and bacterial load in the respiratory tract. J o u r n a l P r e -p r o o f We consider that PDT is not a "Viral Killing tool" which is able to combat the virus systemically, but rather, it can be applied as an efficient therapy to decrease the microbial load (viral and bacterial) in the respiratory tract. In this regard, PDT is a safe and well-established treatment option able to generate ROS and 1 O2 which can promote the damage of viruses targets [3] such as nucleic acids (DNA or RNA), envelope and core proteins and, if present, viral lipids and membrane lipid, protein complexes, cytosolic enzymes for bacteria which can be present in a biofilm matrix. [4] The propagation of opportunistic pathogens occurs mainly through the upper respiratory tract due to its natural colonization in the oropharynx. The pharyngotonsillitis PDT can help not only to reduce the number of these microorganisms present in the oropharynx but also to prevent their penetration into the mucosal barrier and thus helping the performance of phagocytes which can decrease their access using nutrients on the mucosal surface for their proliferation. As a selected example, Blanco and co-authors reported a clinical PDT protocol against pharyngotonsillitis and a reduction more than 90% of the symptoms related to the disease after 24 h was observed [5] (Figure 1 ). Moreover, nebulization is described as an efficient method of delivering drugs directly to the respiratory tract. The Optics's group at the CEPOF-USP performed a proof-of-concept through an efficient photodynamic protocol against bacterial pneumonia using an extracorporeal illumination in the infrared region (at 780 nm) and nebulized indocyanine green as photosensitizer [6, 7] (Figure 2) . The authors observed no deaths occurred in PDT group, whereas 60% of the control group died. This protocol is an important step toward clinical implementation which PDT can be applied as a single therapy or as an antibiotics adjuvant. Thus far, many photodynamic protocols in respiratory tract have been the subject for a proof-of-principle in pre-clinical studies, showing a potential clinical treatment against infections disease like COVID-19 and its correlated infections. However, further studies are warranted to confirm the design of an "ideal" photodynamic protocol. Presently we are investing in the clinical implementation for the procedure. The killers within: The deadly rise of drug-resistant bacteria Trends and targets in antiviral phototherapy Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections Treatment of recurrent pharyngotonsillitis by photodynamic therapy Nebulization as a tool for photosensitizer delivery to the respiratory tract Pneumonia treatment by photodynamic therapy with extracorporeal illumination -an experimental model None.